PCC probiomics limited
Add to My Watchlist 2.22% ! 22.0¢

Hi abdm,PCC and soon BXN is all about the Hunter Immunology...

  1. helmel
    360 Posts.
    clock Created with Sketch.
    03/04/12
    15:45
    Post #: 9936212
    Hi abdm,

    PCC and soon BXN is all about the Hunter Immunology IP.The Phase IIb trial results will be released soon.The trial was completed at the end of the last Australian winter.

    A positive result (for an oral vaccine to treat COPD-Chronic Obstructive Pulmonary Disorder,the new name for emphysema and chronic bronchitis) would be very very positive for PCC holders.It would not only suggest a very valuable product for a huge health problem,but would also offer proof of concept for the IP in many other disease areas.

    The old PCC/probiotics market is not the main game at all.


    PCC Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Significant gold intercepts below Samat and Sorowar pits in resource drilling update
right-arrow Created with Sketch.
NEWS Rincon Lithium Project to be powered by 40MW energy infrastructure
right-arrow Created with Sketch.
NEWS Blue Moon first wedge hole intersects 543g/t gold over 1.2m in laminated quartz vein
right-arrow Created with Sketch.
NEWS Gold and Copper Targets Identified by Koonenberry at Prince of Wales Project
right-arrow Created with Sketch.
VMM Colossus PFS Unlocks World-Class Project Economics and Positions Viridis for Global Leadership
right-arrow Created with Sketch.
NUZ Positive FDA feedback on NUZ-001 strategy to lift clinical hold
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.